Live from the NIH registry
Studies recruiting near Palm Bay right now
Top 25 of 72 recruiting studies, sorted by proximity — each links to its official registry page
BMS-986489 (Atigotatug + Nivolumab) vs Durvalumab in Limited-stage Small-cell Lung Cancer (TIGOS-LS)
Limited Stage Small Cell Lung Cancer
Phase 2
Interventional 250 participants sought
Cancer Care Centers of Brevard — Palm Bay, Florida (6.5 mi)
· Sponsor: SCRI Development Innovations, LLC
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
NSCLC (Non-small Cell Lung Cancer), Non-Small Cell Lung Cancer
Phase 3
Interventional 590 participants sought
Cancer Care Centers of Breevard — Rockledge, Florida (27.1 mi)
· Sponsor: Revolution Medicines, Inc.
A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH
Metabolic Dysfunction-Associated Steatohepatitis, Non-alcoholic Fatty Liver Disease
Phase 2
Interventional 42 participants sought
GSK Investigational Site — Viera, Florida (20.2 mi)
· Sponsor: GlaxoSmithKline
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis
Phase 3
Interventional 762 participants sought
89bio Clinical Study Site — Viera, Florida (20.2 mi)
· Sponsor: 89bio, Inc.
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
Intestinal Neoplasms, Gastrointestinal Neoplasms
Phase 3
Interventional 800 participants sought
Cancer Care Centers of Brevard, Inc. — Palm Bay, Florida (6.5 mi)
· Sponsor: Pfizer
A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)
Metabolic Dysfunction-associated Steatohepatitis
Phase 2
Interventional 160 participants sought
ClinCloud, LLC — Viera, Florida (20.2 mi)
· Sponsor: Eccogene
Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer
Extensive-stage Small-cell Lung Cancer
Phase 3
Interventional 621 participants sought
Cancer Care Centers of Brevard, Inc — Palm Bay, Florida (6.5 mi)
· Sponsor: BioNTech SE
Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.
Relapsing Multiple Sclerosis
Phase 3
Interventional 400 participants sought
Vero Beach Neurology — Vero Beach, Florida (27.6 mi)
· Sponsor: Novartis Pharmaceuticals
The Preeclampsia Registry
Preeclampsia, Eclampsia
N/A
Observational 20,000 participants sought
Preeclampsia Foundation — Melbourne, Florida (8.9 mi)
· Sponsor: Preeclampsia Foundation
A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan, Monotherapy or in Combination With Osimertinib, Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 490 participants sought
Cancer Care Centers of Brevard- Rockledge /ID# 277853 — Rockledge, Florida (27.1 mi)
· Sponsor: AbbVie
Imeroprubart in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Chronic Inflammatory Demyelinating Polyneuropathy
Phase 2
Interventional 162 participants sought
Site Number - 1633 — Rockledge, Florida (27.1 mi)
· Sponsor: Immunovant Sciences GmbH
A Prospective Registry of Vaginal Photobiomodulation for Chronic Pelvic Pain.
Chronic Pelvic Pain
N/A
Observational 1,000 participants sought
Zipper Urogynecology Associates — Melbourne, Florida (8.9 mi)
· Sponsor: SoLa Pelvic Therapy
Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With Diabetic Peripheral Neuropathy
Diabetic Peripheral Neuropathic Pain
Phase 3
Interventional 734 participants sought
ClinCloud - Viera — Viera, Florida (20.2 mi)
· Sponsor: Vertex Pharmaceuticals Incorporated
A Study of Zunveyl on Safety, Tolerability, Neuropsychiatric Symptoms, and Caregiver Distress in Alzheimer's Disease (RESOLVE)
Alzheimer Disease
Phase 4
Interventional 150 participants sought
Clincloud, LLC - Viera Office — Melbourne, Florida (8.9 mi)
· Sponsor: Alpha Cognition, Inc
BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or Metastatic HR+/HER2- Breast Cancer Who Have Not Received Prior Treatment for Advanced or Metastatic Disease
HR+/HER2- Breast Cancer
Phase 3
Interventional 1,056 participants sought
Cancer Care Centers of Brevard Palm Bay — Palm Bay, Florida (6.5 mi)
· Sponsor: BeOne Medicines
A Study Evaluating the Efficacy and Safety of Inavolisib Plus Fulvestrant Compared With Alpelisib Plus Fulvestrant in Participants With HR-Positive, HER2-Negative, PIK3CA Mutated, Locally Advanced or Metastatic Breast Cancer Post CDK4/6i and Endocrine Combination Therapy
Breast Cancer
Phase 3
Interventional 420 participants sought
Cancer Care Centers of Brevard — Palm Bay, Florida (6.5 mi)
· Sponsor: Hoffmann-La Roche
FastWire REvascularisation of Extremities, (For LOWer Limbs) - FREEFLOW
Chronic Total Occlusion of Artery of the Extremities
N/A
Interventional 65 participants sought
Vascular & Embolization Specialists — Cocoa, Florida (29.7 mi)
· Sponsor: Versono Medical Ltd
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
Obesity, Overweight
Phase 3
Interventional 3,003 participants sought
AURORA-1 Clinical Site — Melbourne, Florida (8.9 mi)
· Sponsor: Ascletis Pharma (China) Co., Limited
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
Breast Cancer
N/A
Observational 30,000 participants sought
Cancer Care Centers of Brevard — Rockledge, Florida (27.1 mi)
· Sponsor: Agendia
A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy
Kidney Disease
Phase 3
Interventional 347 participants sought
Panoramic Health - Florida Kidney Physicians, LLC (Melbourne) — Melbourne, Florida (8.9 mi)
· Sponsor: Takeda
Pivotal Study of the Velocity™ pAVF System
Chronic Kidney Disease, Hemodialysis Access
N/A
Interventional 126 participants sought
Vascular and Embolization Specialists — Cocoa, Florida (29.7 mi)
· Sponsor: Venova Medical
A Phase III Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With CKD Stage 3b and 4 (BalanceD-CKD)
Renal Insufficiency, Chronic
Phase 3
Interventional 2,800 participants sought
Research Site — Melbourne, Florida (8.9 mi)
· Sponsor: AstraZeneca
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
Breast Cancer
Phase 3
Interventional 625 participants sought
Research Site — Palm Bay, Florida (6.5 mi)
· Sponsor: AstraZeneca
Clinical Trial on Agitation in Alzheimer's Dementia
Alzheimer Disease, Agitation,Psychomotor
Phase 2
Interventional 164 participants sought
ClinCloud, LLC — Melbourne, Florida (8.9 mi)
· Sponsor: IGC Pharma, LLC
A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)
Carcinoma, Non-Small-Cell Lung
Phase 3
Interventional 630 participants sought
Cancer Care Centers of Brevard, Inc. — Palm Bay, Florida (6.5 mi)
· Sponsor: Mirati Therapeutics Inc.